SynthesisFrontiers in oncology2025

Comparative efficacy of trastuzumab deruxtecan versus guideline-recommended treatments for 2L+ unresectable locally advanced or metastatic HER2-mutant non-small cell lung cancer: a systematic review and indirect treatment comparison.

Federico Cappuzzo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.